Corruption in the Pharmaceutical Trade BAYER AG As an opener to this article that describes very directly what the corporate world of pharmaceuticals is about, I would like to quote Marijn Dekkers, CEO of Bayer AG, December 3, 2013 – “We did not develop this medicine for Indians. We developed it for Western patients who can afford it.” The original Businessweek article has been removed from the internet, including its internet cache and the video that was on ft-live.com . https://www.keionline.org/node/1924 , http://www.dailymail.co.uk/news/article-2545360/Pharmaceutical-chief-tries-stop-India-replicating-cancer-treatment.html Bayer AG can trace its roots back to August 1863 with the creation of “Friedr.Bayer et comp”, a partnership between businessman Friederich Bayer, and Johann Friederich Weskott, a master dyer. This company would specialize in the manufacture of synthetic dyes and was based in Barmen, now part of Wuppertal in Germany. The company grew quickly, exporting dyes a...
Drug Warning: Seroquel #DrugWarning #OffLabelPrescriptions I recently shared an article indicating the number of natural medicines that were removed from the shelves in Canada after their laws basically outlawed CAMs medicines. This is the paradigm they have exchanged that for. This drug was NOT approved for insomnia for a good reason, and has severe side effects, yet became the go-to option. Ironically it is not illegal for a medical professional to prescribe "off label", but it is illegal to advertise off label use. It is left to the discretion of the doctor that did not even bother to read the literature, often influenced by whatever spiel the pharmaceutical rep presented. How ironic that a drug is prescribed for one of its adverse effects with total disregard for the warnings on the package inserts. The whole mindset of the medical trade insulting Complimentary Medicine, yet prescribing off label or using drugs derived from CAMs medicines smacks of hypocrisy. http...
#MedicalMisconduct - Novartis Misconduct in the Pharmaceutical Sector - Novartis By Ronald Gibson 12 July 2017 As the South African Government and Novartis recently signed a memorandum of understanding relating to pharmaceutical research for the development of new medicinal compounds in South Africa, I decided to do my first article covering misconduct in the pharmaceutical sector about Novartis, as we need to have an idea of the ethics we might expect from them. I will mainly focus on information related to their business dealings in the USA, as there are quite a few Government Oversight institutions and non-profit consumer protection bodies that keep track of companies in the USA. Novartis was formed in 1996 after the merger of Ciba-Geigy and Sandoz. Both these companies started off in the production of synthetic fabric dyes, later branching off into pharmaceuticals and agricultural chemicals. During the merger the pharmaceutical and agrochemical divisions of both companies fo...
Comments
Post a Comment